ETV Bharat / bharat

Bharat Biotech announces Covaxin rates

Bharat Biotech announces Covaxin rates
Bharat Biotech announces Covaxin rates
author img

By

Published : Apr 24, 2021, 10:13 PM IST

Updated : Apr 24, 2021, 10:39 PM IST

22:07 April 24

Bharat Biotech announces Covaxin rates

Bharat Biotech announces Covaxin rates
Bharat Biotech announces Covaxin rates

Hyderabad: Bharat Biotech on Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage.

The Hyderabad-based vaccine major also said that it would provide the vaccine to private hospitals at Rs 1,200 per dosage.

Read:| Biological E gets CDSCO nod for phase III trial of COVID-19 vaccine candidate

In a statement, Bharat Biotech Chairman and Managing Director Krishna M Ella said the company is supplying the vaccine to the central government at Rs 150 per dosage and the government on its part is distributing it free of cost.

"We would like to state that more than 50 per cent of our capacities have been reserved for central government supplies," Ella said.

Read:| SII defends pricing, says Covishield 'most affordable vaccine in market'

Recovering the cost is essential in the journey of innovation towards other vaccines such as intranasal Covid-19, Chikungunya, Zika, Cholera and others, he added. 

PTI 

22:07 April 24

Bharat Biotech announces Covaxin rates

Bharat Biotech announces Covaxin rates
Bharat Biotech announces Covaxin rates

Hyderabad: Bharat Biotech on Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage.

The Hyderabad-based vaccine major also said that it would provide the vaccine to private hospitals at Rs 1,200 per dosage.

Read:| Biological E gets CDSCO nod for phase III trial of COVID-19 vaccine candidate

In a statement, Bharat Biotech Chairman and Managing Director Krishna M Ella said the company is supplying the vaccine to the central government at Rs 150 per dosage and the government on its part is distributing it free of cost.

"We would like to state that more than 50 per cent of our capacities have been reserved for central government supplies," Ella said.

Read:| SII defends pricing, says Covishield 'most affordable vaccine in market'

Recovering the cost is essential in the journey of innovation towards other vaccines such as intranasal Covid-19, Chikungunya, Zika, Cholera and others, he added. 

PTI 

Last Updated : Apr 24, 2021, 10:39 PM IST
ETV Bharat Logo

Copyright © 2024 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.